CytRx Corporation | TalkMarkets

Latest Posts

Top Performing Stocks In January And Seasonality

Article By: Cory Mitchell, CMT

Sunday, December 31, 2017 11:33 AM EDT

January is not a good month for the stock market overall. The S&P 500 is usually flat to lower during the month. BUT, there are individual stocks that excel in January, rising at least 70% of the time and producing up to 17% gains during the month.

In this article: ALK, DIS, HRS, LEN, FAX, ALKS, CRUS, ERIC, XLNX, CYTR, EQC, OSK

Read

Incyte Rises After ASCO Abstracts, But Piper Urges Closer Look

Article By: The Fly

Wednesday, May 17, 2017 9:48 PM EDT

The release of study abstracts for next month's ASCO conference drove significant moves tonight in drugmakers, but Piper Jaffray urged caution on the company's data, saying its "not sure what other investors are seeing that we aren't."

In this article: MRK, INCY, NLNK, AMGN, NKTR, CYTR, BLUE, LBIO, LPTX

Read

Cytrx Shares Fall 66% After Phase 3 Sarcoma Trial Failure

Article By: Terry Chrisomalis

Tuesday, July 12, 2016 8:51 AM EDT

The phase 3 trial recruited up to 433 patients to be treated for second-line soft tissue sarcoma. Shares of the company tumbled as data released showed that patients taking Aldoxorubicin failed to improve.

In this article: CYTR

Read

Tuesday Morning Pre-Market Insights: TSLA, SHAK, CYTR, EXAS

Article By: TipRanks

Tuesday, July 21, 2015 9:26 AM EDT

Tesla Motors Inc. shares fell nearly -5% in pre-market trading after the company received a downgrade from Colin Langan at UBS. The analyst lowered his price target on the stock from $220 to $210.

In this article: CYTR, EXAS, GPRO, TSLA

Read